PsychedelicNewsBreaks

MondayMar 05, 2018 2:41 pm

PsychedelicNewsBreaks – Marijuana Company of America, Inc. (MCOA) Offers Hemp-based CBD Products through its hempSMART Line

Innovative hemp and cannabis corporation Marijuana Company of America’s (OTC: MCOA) hempSMART product line continues to deliver new industrial hemp-based CBD products to consumers. An article discussing the company reads: “MCOA delivers turnkey products and services to consumers in U.S. states where the cannabis plant’s derivatives have been legalized. While federal drug policy continues to target state-by-state normalization of cannabis for medicinal and recreational use, MCOA’s hempSMART subsidiary is turning out branded products containing industrial hemp-derived, non-psychoactive cannabidiol (CBD) formulations for retail distribution via an affiliate marketing model.” To view the full article, visit http://cnw.fm/9HayA About Marijuana Company of America,…

Continue Reading

MondayFeb 26, 2018 9:29 am

PsychedelicNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters Global Licensing Agreement with Neutrisci International Inc. (TSX-V: NU) (OTCQB: NRXCF)

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) this morning said it has entered an agreement with NeutriSci International Inc. (TSX-V: NU) (OTCQB: NRXCF) resulting in NeutriSci now having 100% ownership of Ambarii Trade Corporation. Lexaria has also granted to NeutriSci an Intellectual Property License and Supply Agreement for the manufacturing and sale of CBD based products. Per the License Agreement, NeutriSci will remain focused on the development and sales of its existing and pipeline products that include Lexaria's technology for enhancing palatability and bioavailability of beneficial non-psychoactive cannabinoids. Lexaria will receive continuing royalty revenues from the sales generated by these products.…

Continue Reading

TuesdayFeb 20, 2018 9:56 am

PsychedelicNewsBreaks – Marijuana Company of America, Inc. (MCOA) Expands hempSMART™ Line with Full Spectrum Pet Drops

Innovative hemp and cannabis corporation Marijuana Company of America (OTC: MCOA) this morning announced the release of hempSMART™ Full Spectrum Pet Drops, a natural product line formulated with 250mg of full spectrum non-psychoactive cannabidiol (“CBD”) derived from industrial hemp. Per the update, in addition to naturally-occurring CBD, the specially-formulated product contains full spectrum hemp extract, fractionated coconut oil and a rich bacon flavor. “Our new hempSMART product is a natural option for pet owners who care about supporting their animals’ healthy energy levels as well as optimizing their health,” Donald Steinberg, CEO of MCOA, stated in the news release. “Our…

Continue Reading

ThursdayFeb 15, 2018 3:10 pm

PsychedelicNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Utilizes Oral Digestion Technology to Expand Product Line

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) recently announced its entry into a licensing agreement with Cannfections Group Inc. The agreement offers Lexaria the ability to provide commercial clients with high quality chocolate edibles using its proprietary DehydraTECH™ oral digestion technology. An article discussing the company reads: “Lexaria has developed various products for demonstration, testing and sales, showing wide applicability. These non-psychoactive cannabinoid products have a high-absorption hemp oil formula, are an excellent source of omegas and essential fatty acids and are engineered for physiological performance and recovery. APIs within Lexaria’s products have been shown to reduce anxiety and stress while…

Continue Reading

MondayJan 29, 2018 11:38 am

PsychedelicNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Sees Potential to Lower Medication Doses Using Advanced Drug Delivery

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) has developed DehydraTECH™, a drug delivery platform that can be applied to various ingestible products such as foods, beverages, oral suspensions, tablets, capsules and more. An article discussing the company’s innovative drug delivery technology reads: “Lexaria’s DehydraTECH™ oral digestion technology is a ‘back office’ process that allows non-psychoactive cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (“NSAIDs”) and nicotine to be absorbed at much higher rates. The company has been working with the National Research Council of Canada (“NRC”), an agency of the Canadian federal government, to explore the effects of its technology. Lexaria’s superior delivery system…

Continue Reading

ThursdayJan 11, 2018 11:31 am

PsychedelicNewsBreaks – Marijuana Company of America, Inc. (MCOA) Subsidiary Announces Launch of hempSMART™ Pain Cream

Marijuana Company of America, Inc. (OTC: MCOA), through wholly owned subsidiary hempSMART™, Inc., this morning announced the launch of hempSMART Pain Cream. Per the update, each bottle of hempSMART Pain Cream is formulated with 300mg of full spectrum non-psychoactive cannabidiol derived from industrial hemp. Utilizing a proprietary blend of Ayurvedic herbs, menthol, cayenne pepper extract, rosemary oil, aloe gel, white willow bark, arnica, wintergreen extract and tea tree oil, hempSMART Pain Cream provides what the company calls an immediate cooling and soothing sensation. “We are excited to announce the expansion of our hempSMART personal care product line to include pain…

Continue Reading

TuesdayJan 02, 2018 11:33 am

PsychedelicNewsBreaks – India Globalization Capital, Inc.’s (NYSE: IGC) Cannabis-based Eating Disorder Treatment Anticipated for PCT Filing in February

India Globalization Capital (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, has recently developed IGC-506 for the treatment of multiple types of eating disorders in humans, as well as animals in the veterinary market. The company expects to file a Patent Cooperation Treaty (“PCT”) application by February 28, 2018. PCT is an international patent filing effective in numerous foreign countries. An article discussing this reads: “IGC-506 is a combination therapy drug, developed from cannabis-extracts and other compounds, designed to treat multiple types of eating disorders. Cannabinoids are chemical compounds that exert a range…

Continue Reading

ThursdayDec 14, 2017 10:36 am

PsychedelicNewsBreaks – Marijuana Company of America, Inc. (MCOA) Adds New Pain Product to Lineup

Marijuana Company of America (OTC: MCOA) announced today the launch of its new personal care product hempSMART Pain for the temporary treatment of minor pain associated with physical activity using non-psychoactive cannabidiol. "HempSMART demonstrated its commitment to formulating a safe and synergistic natural personal care product. The hempSMART Pain formula harnesses the natural power of premium CBD, CBG and active terpenes derived from industrial hemp, combined with complimentary botanicals,” Paula Vetter, a member of hempSMART's product development team, stated in a news release about the product. To view the full press release, visit http://cnw.fm/G61Yr. About Marijuana Company of America, Inc.…

Continue Reading

FridayDec 08, 2017 12:42 pm

PsychedelicNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) DehydraTech™ Shines in Vegas Lights

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) attracted a lot of attention in Las Vegas at this year’s Marijuana Business Conference & Expo due to increased awareness about potential health benefits of cannabinoids and an increased demand for improved CBD-based edibles. A recent article highlights keen interest in Lexaria’s patented DehydraTECH™ delivery technology, stating, “Lexaria’s proprietary technology has been awarded patents in the U.S. and Australia, and it has patents pending in more than 40 other countries. Furthermore, it is the only company in the world to date that has a patent allowed for the oral delivery of all non-psychoactive cannabinoids,…

Continue Reading

MondayNov 20, 2017 12:54 pm

PsychedelicNewsBreaks – Skinvisible Pharmaceuticals, Inc. (SKVI) Could Have the Solution to the Flu Epidemic

Skinvisible Pharmaceuticals (OTCQB: SKVI) is a topical and transdermal product development company with a proprietary drug delivery system, Invisicare, that improves how ingredients are delivered to and through the skin including the medicinal components of marijuana; specifically, CBD (cannabidiol) and the psychoactive marijuana ingredient THC (tetrahydrocannabinol). The key to Skinvisible's patented technology and trademarked Invisicare family of polymer delivery vehicles is its formula and process for combining hydrophilic and hydrophobic polymers into stable complexes in water emulsions. Applications of this novel technology are discussed in a recent article that says in part, “H7N9 (a type of avian influenza virus) could…

Continue Reading